Federation Des Caisses Desjardins Du Quebec P Lx Pharma Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2024	SELL	$0.0 - $0.36 $0 - $13,764	-38,236 Closed	0 $0
Q4 2022 Aug 14, 2024	SELL	$0.15 - $0.63 $14,801 - $62,165	-98,675 Reduced 72.07%	38,236 $6.27 Million
Q3 2022 Aug 14, 2024	SELL	$0.52 - $3.08 $260 - $1,540	-500 Reduced 0.36%	136,911 $89 Million
Q1 2022 Aug 14, 2024	BUY	$3.54 - $8.3 $486,434 - $1.14 Million	137,411 New	137,411 $555 Million
Q4 2021 Aug 30, 2024	BUY	$7.69 - $19.66 $73,385 - $187,615	9,543 Added 7.08%	144,401 $1.16 Billion
Q3 2021 Aug 30, 2024	BUY	$12.22 - $21.28 $450,795 - $785,019	36,890 Added 37.66%	134,858 $2.6 Billion
Q2 2021 Aug 30, 2024	BUY	$9.0 - $15.94 $881,712 - $1.56 Million	97,968 New	97,968 $1.35 Billion
Q1 2021 Aug 30, 2024	BUY	$5.24 - $10.14 $83,693 - $161,956	15,972 New	15,972 $144 Million

Others Institutions Holding PLXP

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About PLx Pharma Inc.

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

More about PLXP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account